InvertirStartups
ENES
Company Profile

🩺 Eywa Biotech

Biotech for mental-health treatment.

🩺 Biotech / mental healthMexicoSeed
Country
Mexico
Sector
Biotech / mental health
Latest disclosed round
Seed
Amount
US$2.5M
Backers
Not disclosed
Reviewed

About

Eywa Biotech's backers have not been publicly disclosed as of 2026-07-16.

What "Seed" means

the round that follows early traction: some usage, revenue or a working product, raised to prove the business model scales before a larger institutional round. Still high-risk, but one step past the founding idea.

Why biotech / mental health is attracting capital

Health and biotech is one of the busiest early-stage categories across Latin America right now, spanning AI-assisted diagnostics, telehealth and admin automation for clinics — all sectors where regulatory approval and clinical validation, not just software, become the real bottleneck to scale.

Before you read anything into this

Eywa Biotech is not investable by the general public — this round was private, and nothing on this page is a recommendation, a rating or a prediction. Inclusion on our early-stage watchlist means a credible public source reported this round with a named stage; we have not done diligence on the company and have no view on its prospects. Most early-stage startups fail.

Understand the actual routes into deals like this one:
How to invest in startups →

← All startups on the watchlist

Frequently asked questions

Can I invest directly in Eywa Biotech?
Almost certainly not. Eywa Biotech raised this round privately from venture investors, not the public. The realistic routes into early-stage deals generally are regulated equity crowdfunding, a syndicate, or a venture fund — see our guide to the four routes.
What does "Seed" mean?
the round that follows early traction: some usage, revenue or a working product, raised to prove the business model scales before a larger institutional round. Still high-risk, but one step past the founding idea.
Does appearing on this list mean Eywa Biotech is a good investment?
No. Inclusion means a credible source reported a recent early-stage round, nothing more. We have not done diligence on this company, and the base rate for early-stage startups is failure.
Where does this information come from?
Compiled from public reporting as part of our early-stage watchlist, which lists the review date and full sources. Funding stages change quickly — check the company's own site or a deal database before relying on any detail here.